Lv31
230 积分 2024-03-12 加入
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
1个月前
已完结
Mapping the patent landscape of TROP2-targeted biologics through deep learning
1个月前
已完结
Expression of Membrane Targets for Therapeutics in RET-Positive Non–Small Cell Lung Cancer
1个月前
已完结
Engineering pyroptotic vesicles as personalized cancer vaccines
3个月前
已完结
Pilot Study of Nectin-4–Targeted PET Imaging Agent68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
6个月前
已关闭
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non–Small Cell Lung Cancer
7个月前
已完结
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
7个月前
已完结
Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms
11个月前
已完结
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
1年前
已完结
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
1年前
已完结
皖公网安备34019202002308
